The Marketing Authorisation Holder, Novo Nordisk® has alerted the Malta Medicines Authority that one pack of Ozempic® 1mg solution for injection in pre-filled pen from batch number PP5N682::RN287 is suspected to be possibly falsified.

The Malta Medicines Authority said that as a precautionary measure based on the report of Novo Nordisk®, a patient-level recall of Ozempic® 1mg solution for injection in pre-filled pen with the following batch number and expiry date is being carried out.

This recall applies to this batch only.

Batch Number PP5N682::RN287

Expiry Date 02/2027

If anyone is in possession of Ozempic® 1mg solution for injection in pre-filled pen belonging to this batch then:

Stop using the affected product

Contact the pharmacy to verify the batch

Return the affected pack to the pharmacy from where the pack was purchased

Speak to a pharmacist or medical practitioner to seek continuation of treatment

The Superintendent of Public Health as the Licencing Authority with the assistance of the Malta Medicines Authority said that they are actively working with the relevant stakeholders to safeguard any possible risk to public health.

For any questions or concerns, the public should speak to their pharmacist or medical practitioner for guidance.

Photo: DOI

Permalink: Recall alert for Ozempic® Batch Number – PP5N682::RN287 – Malta